TMO Thermo Fisher Scientific
Data as of close
Healthcare · Measuring & Controlling Devices, Nec
Thermo Fisher Scientific (TMO) is a healthcare company in the Measuring & Controlling Devices, Nec industry, with a market capitalization of $253.0 billion. Shares last traded at $682.77, 4.1% below their 52-week high. Over the past year the stock is up 22.8%. TMO trades at a price-to-earnings ratio of 35.77, below the Measuring & Controlling Devices, Nec median of 40.70. Net profit margin is 14.9%, above the peer median of -1.6%. Revenue grew 3.9% year over year. The shares yield 0.3% in dividends.
* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-09-26. Source: SEC EDGAR/XBRL.
TMO Dividend History
| Fiscal year end | Total dividends paid | Per share* | Payout ratio |
|---|---|---|---|
| 2025-12-31 | $636M | $1.68 | 9% |
| 2024-12-31 | $583M | $1.52 | 9% |
| 2023-12-31 | $523M | $1.35 | 9% |
| 2022-12-31 | $455M | $1.15 | 7% |
| 2021-12-31 | $395M | $0.99 | 5% |
| 2020-12-31 | $337M | $0.84 | — |
| 2019-12-31 | $297M | $0.74 | — |
| 2018-12-31 | $266M | $0.66 | — |
| 2017-12-31 | $237M | $0.60 | — |
| 2016-12-31 | $238M | $0.60 | — |
| 2013-12-31 | $216M | $0.59 | 17% |
| 2012-12-31 | $142M | $0.39 | 12% |
*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.
Compare payers on the highest-dividend-yield screener.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q3 2026 | $4.64 | 2026-10-30 |
| Q2 2026 | $4.68 | 2026-07-31 |
| Q1 2026 | $4.43 | 2026-05-01 |
| Q4 2025 (derived) | $5.21 | 2026-02-26 |
| FY 2025 | $17.74 | 2026-02-26 |
| Q3 2025 | $4.27 | 2025-10-31 |
Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.
Measuring & Controlling Devices, Nec peers
TMO vs 10 industry peers (Measuring & Controlling Devices, Nec), by market cap. Data as of close
| TMO | Thermo Fisher Scientific | $253.0B | 35.77 | 5.34 | 14.9% | -2.03% |
| ROK | Rockwell Automation | $48.9B | 40.70 | 5.45 | 13.4% | +0.87% |
| TRMB | Trimble Inc. | $15.4B | — | 4.06 | -2.8% | +1.42% |
| ONTO | Onto Innovation | $9.4B | — | 9.34 | -0.4% | -5.02% |
| MIR | Mirion Technologies, Inc. | $4.5B | 154.26 | 4.14 | 2.7% | +1.69% |
| QSI | Quantum-Si Inc | $274M | — | 170.47 | — | -13.79% |
| OWLT | Owlet, Inc. | $126M | — | 1.10 | -7.8% | +6.28% |
| GEOS | GEOSPACE TECHNOLOGIES CORP | $53M | — | 0.58 | -43.1% | -7.01% |
| BCHT | Birchtech Corp. | $29M | — | 1.49 | -15.8% | -5.65% |
| NIKI | Niki BioSolutions, Inc. | $1M | — | — | — | -3.24% |
🇨🇦 Thermo Fisher Scientific also trades on Cboe Canada as a CAD-hedged Canadian Depositary Receipt (CDR) under TMO. A CDR represents the same underlying TMO shares in Canadian dollars with the currency exposure hedged; this page tracks the US-listed shares.
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.